V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196193 | 20125122 | 1.75 | 56 | 03 | 2018-04-04 | 2018-04-08 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100301396 |
| 20196197 | 20125123 | 1.77 | 74.05 | Palliative (P) | 2019-08-27 | 2020-01-31 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100991149 |
| 20196198 | 20125124 | 1.72 | 75 | Palliative (P) | 2020-01-05 | 2020-01-08 | CETUXIMAB | N | N | CETUXIMAB | 100100818 |
| 20196200 | 20125125 | 1.88 | 86.4 | Curative (C) | 2019-08-28 | 2019-09-19 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100121292 |
| 20196201 | 20125126 | 1.52 | 68.2 | Palliative (P) | 2016-07-01 | 2017-06-18 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101636024 |
| 20196203 | 20125127 | 1.49 | 103.6 | Palliative (P) | 2018-10-28 | 2018-11-07 | CETUXIMAB | 02 | N | CETUXIMAB | 101464327 |
| 20196205 | 20125128 | 1.87 | 67.6 | null | 2017-09-17 | 2017-09-24 | Trastuzumab | 02 | null | TRASTUZUMAB | 100818753 |
| 20196206 | 20125129 | 1.7 | 77.4 | Palliative (P) | 2019-03-26 | 2019-04-05 | Trastuzumab | 02 | N | TRASTUZUMAB | 101635059 |
| 20196207 | 20125130 | 1.74 | 77.7 | Palliative (P) | 2018-07-22 | 2018-07-22 | Trastuzumab | N | N | TRASTUZUMAB | 101072396 |
| 20196214 | 20125131 | 1.57 | 75 | Palliative (P) | 2018-12-23 | 2019-07-13 | CETUXIMAB | 02 | N | CETUXIMAB | 100139964 |
| 20196216 | 20125132 | 1.51 | 71 | Curative (C) | 2016-07-07 | 2016-07-07 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101829209 |
| 20196217 | 20125133 | 1.82 | 68 | Palliative (P) | 2018-09-12 | 2018-11-11 | CETUXIMAB | 02 | N | CETUXIMAB | 101213082 |
| 20196220 | 20125134 | 1.75 | 72.5 | Curative (C) | 2018-06-03 | 2018-06-17 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101022604 |
| 20196221 | 20125135 | 1.83 | 75 | null | 2014-06-01 | 2017-06-04 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 100842765 |
| 20196224 | 20125136 | 1.75 | 99.9 | Palliative (P) | 2019-01-10 | 2019-04-24 | Trastuzumab | 02 | N | TRASTUZUMAB | 100346927 |
| 20196228 | 20125137 | 1.74 | 51.8 | null | 2016-06-30 | 2016-07-08 | Cetuximab 14 day | 02 | null | CAPECITABINE + CISPLATIN | 100241690 |
| 20196233 | 20125138 | 1.63 | 92.2 | Palliative (P) | 2019-06-10 | 2019-06-17 | CETUXIMAB | N | N | TRASTUZUMAB | 100513282 |
| 20196235 | 20125139 | 1.8 | 92 | Curative (C) | 2017-03-10 | 2017-03-17 | Trastuzumab Subcutaneous | 99 | null | TRASTUZUMAB | 101590457 |
| 20196239 | 20125140 | 1.72 | 97.5 | Curative (C) | 2016-09-27 | 2017-02-13 | Capecitabine + Cisplatin | 01 | null | CAPECITABINE + CISPLATIN | 100206196 |
| 20196250 | 20125141 | 1.73 | 54.5 | Palliative (P) | 2019-05-13 | 2019-06-07 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101120491 |
| 20196255 | 20125142 | 1.53 | 100 | Curative (C) | 2017-06-25 | 2017-09-21 | CETUXIMAB | N | null | CETUXIMAB | 100508842 |
| 20196256 | 20125143 | 1.64 | 57.6 | Adjuvant (A) | 2018-05-08 | 2018-05-13 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 100558802 |
| 20196264 | 20125144 | 1.59 | 86.4 | Adjuvant (A) | 2017-01-01 | 2017-01-09 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100057688 |
| 20196266 | 20125145 | 1.81 | 75 | Curative (C) | 2017-11-06 | 2017-11-06 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101131842 |
| 20196268 | 20125146 | 1.75 | 80.6 | 02 | 2017-09-18 | 2017-10-10 | TRASTUZUMAB | N | null | TRASTUZUMAB | 100992481 |
| 20196270 | 20125147 | 1.76 | 71 | null | 2017-04-11 | 2017-05-02 | CETUXIMAB | N | N | CETUXIMAB | 101203033 |
| 20196271 | 20125148 | 1.88 | 63.3 | Adjuvant (A) | 2018-12-09 | 2018-12-23 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100317694 |
| 20196277 | 20125149 | null | null | Curative (C) | 2018-11-03 | 2018-11-26 | Trastuzumab 21 day maintenance | 2 | N | TRASTUZUMAB | 100401513 |
| 20196282 | 20125150 | null | null | Curative (C) | 2017-08-23 | 2017-09-20 | CETUXIMAB | 99 | null | CETUXIMAB | 101108412 |
| 20196283 | 20125151 | 1.66 | 72 | Curative (C) | 2016-08-10 | 2017-06-23 | CETUXIMAB | 99 | Y | CAPECITABINE + CISPLATIN | 101430577 |
| 20196289 | 20125152 | 1.77 | 100.8 | Adjuvant (A) | 2017-03-06 | 2017-06-22 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100826138 |
| 20196290 | 20125153 | 1.66 | 70.25 | Palliative (P) | 2019-01-11 | 2019-02-04 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101086706 |
| 20196294 | 20125154 | 1.82 | 87.6 | Curative (C) | 2018-12-02 | 2019-06-26 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101387817 |
| 20196295 | 20125155 | 1.72 | 53 | Palliative (P) | 2017-07-24 | 2017-07-24 | Capecitabine + Cisplatin | 99 | N | CAPECITABINE + CISPLATIN | 100543209 |
| 20196296 | 20125156 | 1.92 | 88.3 | Palliative (P) | 2016-11-03 | 2016-11-17 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101529178 |
| 20196300 | 20125157 | null | null | null | 2015-12-12 | 2016-07-11 | CETUXIMAB | 99 | N | CETUXIMAB | 100623030 |
| 20196301 | 20125158 | 1.72 | 66.3 | Adjuvant (A) | 2017-11-15 | 2017-11-20 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100430564 |
| 20196307 | 20125159 | 1.66 | 93.44 | Palliative (P) | 2016-09-09 | 2016-09-22 | CETUXIMAB | 02 | N | CETUXIMAB | 101700200 |
| 20196308 | 20125160 | 1.75 | 75 | null | 2016-11-29 | 2016-12-06 | CETUXIMAB | 02 | null | CETUXIMAB | 101223787 |
| 20196309 | 20125161 | 1.69 | 87.6 | Palliative (P) | 2016-06-03 | 2016-06-10 | CETUXIMAB | 02 | N | CETUXIMAB | 100645619 |
| 20196317 | 20125162 | 1.55 | 63.8 | Adjuvant (A) | 2021-10-18 | 2021-11-15 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100399079 |
| 20196318 | 20125163 | 1.7 | 56.95 | Neo-adjuvant (N) | 2016-11-23 | 2016-12-02 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101653881 |
| 20196319 | 20125164 | 1.88 | 75.8 | Curative (C) | null | 2019-09-05 | CETUXIMAB | N | N | CETUXIMAB | 100604560 |
| 20196323 | 20125165 | 1.85 | 71.8 | Neo-adjuvant (N) | 2014-07-26 | 2017-04-25 | Trastuzumab | 02 | null | TRASTUZUMAB | 101265576 |
| 20196326 | 20125166 | 1.61 | 91 | Palliative (P) | 2018-03-24 | 2018-08-17 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100744256 |
| 20196329 | 20125167 | null | null | null | 2016-08-22 | 2016-09-06 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 100155574 |
| 20196335 | 20125168 | 1.66 | 106.6 | Palliative (P) | 2019-01-14 | 2019-02-01 | CETUXIMAB | 02 | N | CETUXIMAB | 100013456 |
| 20196342 | 20125169 | 1.72 | 112.4 | Adjuvant (A) | 2017-08-19 | 2017-08-19 | Trastuzumab 21 day maintenance | 99 | N | TRASTUZUMAB | 101790333 |
| 20196343 | 20125170 | 1.82 | 92.1 | null | 2020-01-13 | 2020-02-03 | CETUXIMAB | 2 | N | CAPECITABINE + CISPLATIN | 100135053 |
| 20196346 | 20125171 | 1.55 | 119.1 | Adjuvant (A) | 2019-06-27 | 2019-07-19 | CETUXIMAB | N | Y | CETUXIMAB | 100736934 |